| symbol |
AMDA |
|---|
| 会社名 | Amedica Corp （アメディカ） |
|---|
| 分野（sector） |
Health Care
ヘルスケア
|
|---|
| 産業（industry） |
Medical/Dental Instruments
|
|---|
| 業種 |
医療機器_医療用品_ディストリビュ―タ―
医療関連（Health Care）
|
|---|
| 概要 |
事業概要 Amedica Corporation incorporated on December 10 1996 is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company has developed a femoral head that is made from its solid silicon nitride which could be used for total hip replacement product candidates. It has also developed a femoral condyle design made from its solid silicon nitride. The Company is incorporating its silicon nitride technology into components for use in total hip and knee replacement product candidates. The Company markets and sells its products to surgeons and hospitals in the United States and certain markets in Europe and South America. アメディカは米国のバイオマテリアル会社。特許取得済みの窒化ケイ素技術の利用に焦点を当てて、脊髄と関節形成用途のインプラントを製造・販売。製品には、高密度耐荷重性固体の固体窒化ケイ素(MC2)、多孔質骨様網状構造化の多孔質窒化ケイ素 (CSC)、骨の成長を促進するためのMC2とCSCを組み合わせた複合材料、他の生体材料用の塗装膜がある。
|
|---|
| 本社所在地 | 1885 West 2100 South Salt Lake City UT 84119 USA |
|---|
| 代表者氏名 | B. Sonny Bal B.ソニー・バル |
|---|
| 代表者役職名 | Chairman of the Board President Chief Executive Officer Chief Financial Officer |
|---|
| 電話番号 | +1 801-839-3516 |
|---|
| 設立年月日 | 35400 |
|---|
| 市場名 | NASDAQ Small Cap |
|---|
| ipoyear | 2014年 |
|---|
| 従業員数 | 66人 |
|---|
| url | www.amedicacorp.com |
|---|
| nasdaq_url | https://www.nasdaq.com/symbol/amda |
|---|
| adr_tso | ― |
|---|
| EBITDA | EBITDA（百万ドル） -10.59300 |
|---|
| 終値（lastsale） | 0.2585 |
|---|
| 時価総額（marketcap） | 3068363.7215 |
|---|
| 時価総額 | 時価総額（百万ドル） 3.20368 |
|---|
| 売上高 | 売上高（百万ドル） 9.72000 |
|---|
| 企業価値(EV) | 企業価値(EV)（百万ドル） -3.15232 |
|---|
| 当期純利益 | 当期純利益（百万ドル） -20.15800 |
|---|
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Amedica Corporation revenues decreased 26% to $4.3M. Net loss applicable to common stockholders increased from $2.2M to $13M. Revenues reflect Domestic segment decrease of 27% to $4.2M. Higher net loss reflects Offering costs increase from $131K to $682K (expense) Interest expense increase of 74% to $1.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.74 to -$2.30. |
|---|
AMDA - アメディカ （Amedica Corporation） アメディカ